ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Achilles' US IPO closed with proceeds of $175m
April 09, 2021Cancer Research UK spinout Achilles Therapeutics has closed its Initial Public Offering in the US bagging gross proceeds of $175.5 million. -
Syncona invests $80m in Freeline’s systemic disease gene therapies
December 23, 2019Syncona has committed to investing $80m in gene therapy-focused Freeline’s Series C financing round. -
Syncona powers gene therapy startup Freeline to £88M B round
June 25, 2018Syncona has dialed up its bet on gene therapy startup Freeline Therapeutics. The life science investor committed £85 million ($112 million) to Freeline’s £88 million series B round, thereby maintaining a big stake in a biotech that is working to redefine
Pharma Sources Insight January 2025
